Article
Decreasing <i>pfmdr1</i> Copy Number Suggests that Plasmodium falciparum in Western Cambodia Is Regaining <i>In Vitro</i> Susceptibility to Mefloquine
26 Feb 2015
Abstract excerpt
Dihydroartemisinin-piperaquine is the current frontline artemisinin combination therapy (ACT) for Plasmodium falciparum malaria in Cambodia but is now failing in several western provinces. To investigate artesunate plus mefloquine (AS+MQ) as a replacement ACT, we measured the prevalence of multiple pfmdr1 copies--a molecular marker for MQ resistance--in 844 P. falciparum clinical isolates collected in 2008 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
